Novavax, Inc. (NVAX)
USD 8.63
(-4.11%)
USD 8.63
(-4.11%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 280.63 Million USD | -48.96% |
| 2022 | 549.78 Million USD | 21.1% |
| 2021 | 453.99 Million USD | 40.98% |
| 2020 | 322.03 Million USD | 0.05% |
| 2019 | 321.87 Million USD | 0.84% |
| 2018 | 319.18 Million USD | 0.45% |
| 2017 | 317.76 Million USD | 0.45% |
| 2016 | 316.33 Million USD | 79985.82% |
| 2015 | 395 Thousand USD | -60.42% |
| 2014 | 998 Thousand USD | -54.3% |
| 2013 | 2.18 Million USD | 81.24% |
| 2012 | 1.2 Million USD | 276.56% |
| 2011 | 320 Thousand USD | -20.0% |
| 2010 | 400 Thousand USD | -17.7% |
| 2009 | 486 Thousand USD | -97.88% |
| 2008 | 22.9 Million USD | 0.7% |
| 2007 | 22.74 Million USD | -1.9% |
| 2006 | 23.18 Million USD | -24.05% |
| 2005 | 30.53 Million USD | -17.85% |
| 2004 | 37.16 Million USD | -11.86% |
| 2003 | 42.16 Million USD | 1.84% |
| 2002 | 41.4 Million USD | 20.58% |
| 2001 | 34.33 Million USD | 71.69% |
| 2000 | 20 Million USD | 19900.0% |
| 1999 | 100 Thousand USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 229.33 Million USD | -18.28% |
| 2024 Q2 | 233.24 Million USD | 1.71% |
| 2023 Q1 | 199.05 Million USD | -63.79% |
| 2023 Q4 | 280.63 Million USD | 26.35% |
| 2023 Q3 | 222.11 Million USD | 11.64% |
| 2023 Q2 | 198.94 Million USD | -0.06% |
| 2023 FY | 280.63 Million USD | -48.96% |
| 2022 FY | 549.78 Million USD | 21.1% |
| 2022 Q3 | 438.09 Million USD | -2.3% |
| 2022 Q4 | 549.78 Million USD | 25.49% |
| 2022 Q1 | 440.49 Million USD | -2.97% |
| 2022 Q2 | 448.42 Million USD | 1.8% |
| 2021 Q4 | 453.99 Million USD | 6.3% |
| 2021 FY | 453.99 Million USD | 40.98% |
| 2021 Q1 | 460.23 Million USD | 42.91% |
| 2021 Q2 | 430.32 Million USD | -6.5% |
| 2021 Q3 | 427.08 Million USD | -0.75% |
| 2020 FY | 322.03 Million USD | 0.05% |
| 2020 Q3 | 440.63 Million USD | 37.13% |
| 2020 Q2 | 321.32 Million USD | 0.11% |
| 2020 Q1 | 320.96 Million USD | -0.28% |
| 2020 Q4 | 322.03 Million USD | -26.92% |
| 2019 Q1 | 323.03 Million USD | 1.21% |
| 2019 FY | 321.87 Million USD | 0.84% |
| 2019 Q4 | 321.87 Million USD | 0.13% |
| 2019 Q3 | 321.44 Million USD | 0.48% |
| 2019 Q2 | 319.89 Million USD | -0.97% |
| 2018 FY | 319.18 Million USD | 0.45% |
| 2018 Q1 | 318.11 Million USD | 0.11% |
| 2018 Q2 | 318.47 Million USD | 0.11% |
| 2018 Q3 | 318.83 Million USD | 0.11% |
| 2018 Q4 | 319.18 Million USD | 0.11% |
| 2017 Q1 | 316.69 Million USD | 0.11% |
| 2017 Q4 | 317.76 Million USD | 0.11% |
| 2017 Q3 | 317.4 Million USD | 0.11% |
| 2017 FY | 317.76 Million USD | 0.45% |
| 2017 Q2 | 317.05 Million USD | 0.11% |
| 2016 FY | 316.33 Million USD | 79985.82% |
| 2016 Q4 | 316.33 Million USD | 0.1% |
| 2016 Q2 | 315.77 Million USD | 0.08% |
| 2016 Q1 | 315.52 Million USD | 79779.24% |
| 2016 Q3 | 316.02 Million USD | 0.08% |
| 2015 FY | 395 Thousand USD | -60.42% |
| 2015 Q1 | 831 Thousand USD | -16.73% |
| 2015 Q4 | 395 Thousand USD | -26.58% |
| 2015 Q2 | 681 Thousand USD | -18.05% |
| 2015 Q3 | 538 Thousand USD | -21.0% |
| 2014 Q4 | 998 Thousand USD | -37.82% |
| 2014 FY | 998 Thousand USD | -54.3% |
| 2014 Q3 | 1.6 Million USD | -11.23% |
| 2014 Q2 | 1.8 Million USD | -10.0% |
| 2014 Q1 | 2 Million USD | -8.01% |
| 2013 Q3 | 2.58 Million USD | 3.9% |
| 2013 FY | 2.18 Million USD | 81.24% |
| 2013 Q4 | 2.18 Million USD | -15.58% |
| 2013 Q2 | 2.49 Million USD | 26.98% |
| 2013 Q1 | 1.96 Million USD | 62.74% |
| 2012 Q4 | 1.2 Million USD | -4.29% |
| 2012 Q1 | 407 Thousand USD | 27.19% |
| 2012 FY | 1.2 Million USD | 276.56% |
| 2012 Q2 | 400 Thousand USD | -1.72% |
| 2012 Q3 | 1.25 Million USD | 214.75% |
| 2011 FY | 320 Thousand USD | -20.0% |
| 2011 Q1 | 380 Thousand USD | -5.0% |
| 2011 Q2 | 360 Thousand USD | -5.26% |
| 2011 Q3 | 340 Thousand USD | -5.56% |
| 2011 Q4 | 320 Thousand USD | -5.88% |
| 2010 Q2 | 440 Thousand USD | -4.35% |
| 2010 Q3 | 420 Thousand USD | -4.55% |
| 2010 Q4 | 400 Thousand USD | -4.76% |
| 2010 Q1 | 460 Thousand USD | -5.35% |
| 2010 FY | 400 Thousand USD | -17.7% |
| 2009 Q4 | 486 Thousand USD | -31.93% |
| 2009 FY | 486 Thousand USD | -97.88% |
| 2009 Q1 | 22.73 Million USD | -0.76% |
| 2009 Q3 | 714 Thousand USD | -87.43% |
| 2009 Q2 | 5.68 Million USD | -75.02% |
| 2008 FY | 22.9 Million USD | 0.7% |
| 2008 Q2 | 22.12 Million USD | -2.83% |
| 2008 Q1 | 22.77 Million USD | 0.1% |
| 2008 Q3 | 22.05 Million USD | -0.31% |
| 2008 Q4 | 22.9 Million USD | 3.85% |
| 2007 Q4 | 22.74 Million USD | 0.64% |
| 2007 Q3 | 22.6 Million USD | 0.8% |
| 2007 Q2 | 22.42 Million USD | -5.36% |
| 2007 FY | 22.74 Million USD | -1.9% |
| 2007 Q1 | 23.69 Million USD | 2.18% |
| 2006 Q3 | 22.73 Million USD | -0.97% |
| 2006 Q4 | 23.18 Million USD | 2.01% |
| 2006 Q1 | 23.17 Million USD | -24.09% |
| 2006 FY | 23.18 Million USD | -24.05% |
| 2006 Q2 | 22.95 Million USD | -0.95% |
| 2005 FY | 30.53 Million USD | -17.85% |
| 2005 Q3 | 36.21 Million USD | -0.68% |
| 2005 Q4 | 30.53 Million USD | -15.69% |
| 2005 Q2 | 36.46 Million USD | -0.97% |
| 2005 Q1 | 36.81 Million USD | -0.93% |
| 2004 FY | 37.16 Million USD | -11.86% |
| 2004 Q2 | 41.43 Million USD | -0.95% |
| 2004 Q1 | 41.83 Million USD | -0.79% |
| 2004 Q3 | 36.4 Million USD | -12.14% |
| 2004 Q4 | 37.16 Million USD | 2.09% |
| 2003 Q3 | 41.52 Million USD | -0.12% |
| 2003 Q4 | 42.16 Million USD | 1.55% |
| 2003 Q1 | 41.6 Million USD | 0.48% |
| 2003 FY | 42.16 Million USD | 1.84% |
| 2003 Q2 | 41.57 Million USD | -0.08% |
| 2002 Q3 | 40 Million USD | 0.0% |
| 2002 Q4 | 41.4 Million USD | 3.51% |
| 2002 FY | 41.4 Million USD | 20.58% |
| 2002 Q1 | 30 Million USD | -12.63% |
| 2002 Q2 | 40 Million USD | 33.33% |
| 2001 FY | 34.33 Million USD | 71.69% |
| 2001 Q1 | 20 Million USD | 0.0% |
| 2001 Q3 | 30 Million USD | 50.0% |
| 2001 Q2 | 20 Million USD | 0.0% |
| 2001 Q4 | 34.33 Million USD | 14.46% |
| 2000 Q1 | 74 Thousand USD | -26.0% |
| 2000 Q2 | 37 Thousand USD | -50.0% |
| 2000 Q3 | - USD | -100.0% |
| 2000 Q4 | 20 Million USD | 0.0% |
| 2000 FY | 20 Million USD | 19900.0% |
| 1999 FY | 100 Thousand USD | 0.0% |
| 1999 Q4 | 100 Thousand USD | -50.0% |
| 1999 Q3 | 200 Thousand USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1998 Q3 | - USD | -100.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -22.317% |
| IO Biotech, Inc. | 2.49 Million USD | -11152.406% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -131037.85% |
| Organovo Holdings, Inc. | 1.39 Million USD | -20031.636% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -574148.005% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -171053.342% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -2759.829% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -3895.373% |
| Savara Inc. | 26.73 Million USD | -949.574% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -41475.556% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1020.657% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1243.765% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -3241986.414% |
| Soligenix, Inc. | 3.49 Million USD | -7930.622% |
| Aptose Biosciences Inc. | 1 Million USD | -27690.982% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1308.74% |
| Century Therapeutics, Inc. | 48.17 Million USD | -482.581% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -570.686% |
| Precision BioSciences, Inc. | 31.26 Million USD | -797.515% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -50.578% |
| Kura Oncology, Inc. | 17.2 Million USD | -1531.599% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Dyadic International, Inc. | 136.92 Thousand USD | -204849.28% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -203.609% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -9671.414% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1908.265% |
| Autolus Therapeutics plc | 52.96 Million USD | -429.83% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -5044.546% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -5031.377% |
| GRI Bio, Inc. | 14 Thousand USD | -2004435.714% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -2158.814% |
| IGM Biosciences, Inc. | 40.5 Million USD | -592.823% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -56.231% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -4650.841% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -33840.501% |
| Opthea Limited | 200.62 Million USD | -39.878% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -381.521% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -384.924% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -2367.772% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -4452.068% |
| Surrozen, Inc. | 3.37 Million USD | -8205.268% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 3.13 Million USD | -8851.392% |
| Ovid Therapeutics Inc. | 46 Million USD | -510.053% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -108.644% |
| Acelyrin, Inc. | 1.19 Million USD | -23403.769% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -231.767% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -134162.272% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -828.763% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -352.09% |
| ADMA Biologics, Inc. | 141.41 Million USD | -98.444% |
| PureTech Health plc | 25.51 Million USD | -1000.012% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -88150.0% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -15963.824% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -2062.724% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -231.43% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -113517.409% |
| ChromaDex Corporation | 3.27 Million USD | -8463.778% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -45017.95% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -47.746% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -169.37% |
| Better Therapeutics, Inc. | 14.88 Million USD | -1785.988% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -816.688% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -152.988% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -636.497% |
| Seer, Inc. | 28.25 Million USD | -893.082% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -4478.059% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -4345.351% |
| Gritstone bio, Inc. | 104.77 Million USD | -167.845% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -9973.044% |
| Avid Bioservices, Inc. | 207.83 Million USD | -35.028% |
| Insmed Incorporated | 1.2 Billion USD | 76.691% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -5303.061% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -7090.238% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -171.051% |
| MediWound Ltd. | 6.71 Million USD | -4081.717% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -176.804% |
| Fortress Biotech, Inc. | 88.59 Million USD | -216.772% |
| OmniAb, Inc. | 25.56 Million USD | -997.903% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -31.177% |
| Zai Lab Limited | 15.15 Million USD | -1752.254% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 41.343% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -784.391% |
| Veracyte, Inc. | 12.63 Million USD | -2121.971% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -5096.944% |
| FibroGen, Inc. | 170.45 Million USD | -64.639% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -13697.204% |
| ContextLogic Inc. | 6 Million USD | -4577.25% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -177517.089% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -4178.625% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 95.159% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -311.307% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -758372.973% |
| ImmuCell Corporation | 11.96 Million USD | -2244.623% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 83.276% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -3735.383% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -9973.044% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -522.623% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -550.085% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -520.38% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -481.88% |
| Vaxxinity, Inc. | 15.16 Million USD | -1750.178% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 66.934% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -27215.12% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1977038.227% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1221.319% |
| Senti Biosciences, Inc. | 37.66 Million USD | -645.062% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -172793.166% |
| Apollomics, Inc. | 4.66 Million USD | -5920.918% |
| 89bio, Inc. | 27.1 Million USD | -935.248% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -143.668% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -62184.301% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -3963.64% |
| Ardelyx, Inc. | 55.98 Million USD | -401.295% |
| Pluri Inc. | 29.61 Million USD | -847.707% |
| Prothena Corporation plc | 11.83 Million USD | -2271.229% |
| Pulmatrix, Inc. | 8.75 Million USD | -3105.059% |
| Celularity Inc. | 65.41 Million USD | -328.994% |
| MeiraGTx Holdings plc | 89.26 Million USD | -214.388% |
| Omeros Corporation | 338.28 Million USD | 17.041% |
| Ainos, Inc. | 5.96 Million USD | -4605.833% |
| Humacyte, Inc. | 58.1 Million USD | -382.971% |
| Mesoblast Limited | 118.92 Million USD | -135.98% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -15044.9% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -5654.255% |
| Blueprint Medicines Corporation | 774.12 Million USD | 63.748% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -5492.567% |
| Summit Therapeutics Inc. | 106.09 Million USD | -164.503% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -353.97% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -143.298% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -789.549% |
| Cytokinetics, Incorporated | 755.77 Million USD | 62.868% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -1996.795% |
| Nutriband Inc. | 241.28 Thousand USD | -116208.515% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -5033.254% |
| Roivant Sciences Ltd. | 499.74 Million USD | 43.845% |
| Evogene Ltd. | 1.13 Million USD | -24560.369% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -22790.294% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -508619.297% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 83.87% |
| BioLineRx Ltd. | 11.59 Million USD | -2321.146% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1603.296% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -13137.5% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -187.515% |
| MediciNova, Inc. | 215.92 Thousand USD | -129868.137% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -11147.896% |
| MiMedx Group, Inc. | 48.09 Million USD | -483.453% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 32.381% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -7717.131% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -17064.22% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -343478.599% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2963.366% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1812.855% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -923.655% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -2189.403% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -2144.003% |
| Allakos Inc. | 41.46 Million USD | -576.8% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -2493.429% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -185750.993% |
| BioAtla, Inc. | 2.46 Million USD | -11307.927% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -195.029% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -4960.133% |
| Precigen, Inc. | 7.09 Million USD | -3854.276% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| XOMA Corporation | 124.45 Million USD | -125.5% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1382.253% |
| Incyte Corporation | 38.28 Million USD | -632.977% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -550.115% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -2419.618% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -17.602% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -977.583% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -80311.175% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -85854.37% |
| UroGen Pharma Ltd. | 100.21 Million USD | -180.036% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -53.563% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -80928.29% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -91911.475% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -4005.852% |
| Chimerix, Inc. | 2.14 Million USD | -12989.319% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -689.292% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -162423.961% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -958.481% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 47 Thousand USD | -596995.745% |
| OncoCyte Corporation | 2.86 Million USD | -9681.631% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -21500.334% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1314349.649% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -186301.557% |
| Purple Biotech Ltd. | 351 Thousand USD | -79852.991% |
| NextCure, Inc. | 6.6 Million USD | -4148.827% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -186.672% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -5264.844% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -22.446% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -28891.219% |
| NLS Pharmaceutics AG | 1.63 Million USD | -17077.395% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 2.79 Million USD | -9944.202% |
| Daré Bioscience, Inc. | 5.31 Million USD | -5176.934% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -49569.912% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -524.244% |
| BeiGene, Ltd. | 930.18 Million USD | 69.83% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -1705.598% |
| Alector, Inc. | 38.91 Million USD | -621.093% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -24495.53% |
| Erasca, Inc. | 55.85 Million USD | -402.399% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1334.959% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -998.118% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -71490.196% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 75.25% |
| Histogen Inc. | 4.62 Million USD | -5971.722% |
| Fortress Biotech, Inc. | 88.59 Million USD | -216.772% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -2748.508% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -344.275% |
| Galecto, Inc. | 249 Thousand USD | -112604.819% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 56.482% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -101.852% |
| Molecular Templates, Inc. | 12.23 Million USD | -2194.644% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1076.587% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -6523.436% |
| Amarin Corporation plc | 8.73 Million USD | -3112.029% |
| TG Therapeutics, Inc. | 110.79 Million USD | -153.292% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -5099.833% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -10939.929% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1388.543% |
| Onconetix, Inc. | 9.88 Million USD | -2738.777% |
| MacroGenics, Inc. | 33.97 Million USD | -726.102% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -19676.956% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Adagene Inc. | 22.3 Million USD | -1158.065% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -33.546% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -2461.707% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1282.915% |
| SciSparc Ltd. | 76 Thousand USD | -369156.579% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -242.168% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -85199.392% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1009.317% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -36.286% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -424.885% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 89.539% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -3564.888% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -445352.381% |
| 2seventy bio, Inc. | 256.67 Million USD | -9.336% |
| Clene Inc. | 32.16 Million USD | -772.594% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -12685.194% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -137526.219% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -3117.922% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Absci Corporation | 15.95 Million USD | -1658.695% |
| XBiotech Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1531.883% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -943.99% |
| Entera Bio Ltd. | 390 Thousand USD | -71857.692% |
| Trevena, Inc. | 35.23 Million USD | -696.512% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1012.086% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -921.048% |
| INmune Bio, Inc. | 10.43 Million USD | -2588.847% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -58214.372% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -4220.12% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -684375.61% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -939.774% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -55925.817% |
| Jaguar Health, Inc. | 35.86 Million USD | -682.585% |
| Clearside Biomedical, Inc. | 43 Million USD | -552.624% |
| NexImmune, Inc. | 68.8 Thousand USD | -407746.357% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -60251.613% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -22823.463% |
| Kronos Bio, Inc. | 28.27 Million USD | -892.625% |
| Innoviva, Inc. | 449.07 Million USD | 37.508% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 41.637% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 89.617% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1287.977% |
| Verastem, Inc. | 41.55 Million USD | -575.301% |
| ProKidney Corp. | 4.41 Million USD | -6259.279% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -17947.267% |
| Imunon, Inc. | 1.62 Million USD | -17172.886% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -22172.619% |
| Statera Biopharma, Inc. | 16.26 Million USD | -1625.802% |
| ImmunityBio, Inc. | 883.67 Million USD | 68.242% |
| Korro Bio, Inc. | 33.2 Million USD | -745.108% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 30.67% |
| Kineta, Inc. | 1.31 Million USD | -21208.656% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -7789.654% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -4900.486% |
| GT Biopharma, Inc. | 58 Thousand USD | -483753.448% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1842.917% |
| Celularity Inc. | 65.41 Million USD | -328.994% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -442.52% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cibus, Inc. | 24.62 Million USD | -1039.82% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -295.394% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -154.295% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -73172.846% |
| Kodiak Sciences Inc. | 181.63 Million USD | -54.507% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -169.592% |
| Annexon, Inc. | 31.35 Million USD | -795.025% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -274.0% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -11882.707% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -3957.178% |
| Moderna, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1926.245% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 80.693% |
| Vor Biopharma Inc. | 35.66 Million USD | -686.974% |
| Eyenovia, Inc. | 16.1 Million USD | -1642.235% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -70058.75% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -151.713% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -509.559% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -773.762% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -28390.863% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -390.578% |
| Immunocore Holdings plc | 84.03 Million USD | -233.962% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -621.056% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -290.818% |
| Alkermes plc | 290.73 Million USD | 3.472% |
| Arcellx, Inc. | 97.62 Million USD | -187.462% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -11349.835% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -513.102% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -431646.154% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -8946.905% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -22154.462% |
| Moolec Science SA | 2.64 Million USD | -10508.86% |
| Biomea Fusion, Inc. | 10.29 Million USD | -2625.67% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 85.89 Million USD | -226.703% |
| Mereo BioPharma Group plc | 5.95 Million USD | -4614.97% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -516.645% |
| Royalty Pharma plc | 6.13 Billion USD | 95.426% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -11583.389% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -16744.838% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -243392.634% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -729.545% |
| Humacyte, Inc. | 58.1 Million USD | -382.971% |
| Structure Therapeutics Inc. | 5.45 Million USD | -5046.432% |
| NLS Pharmaceutics AG | 1.63 Million USD | -17077.395% |
| Genelux Corporation | 2.51 Million USD | -11040.73% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -349261.368% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1759.126% |
| Notable Labs, Ltd. | 2.04 Million USD | -13596.193% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -93222.892% |
| Mustang Bio, Inc. | 2.49 Million USD | -11134.388% |
| Immunovant, Inc. | 138 Thousand USD | -203258.696% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -17098.67% |
| Vericel Corporation | 88.14 Million USD | -218.386% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 81.282% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 29.22 Million USD | -860.289% |
| Orgenesis Inc. | 22.62 Million USD | -1140.595% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -5988.848% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -138143.842% |
| GH Research PLC | 343 Thousand USD | -81717.784% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1258.284% |
| PepGen Inc. | 20.1 Million USD | -1295.916% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -48791.115% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -277756.436% |
| Belite Bio, Inc | 886 Thousand USD | -31574.379% |
| Pharming Group N.V. | 171.54 Million USD | -63.593% |
| XOMA Corporation | 124.45 Million USD | -125.5% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -28742.24% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -17.118% |
| Xencor, Inc. | 83.43 Million USD | -236.356% |
| Replimune Group, Inc. | 75.86 Million USD | -269.894% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1215.62% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -2884.209% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Turnstone Biologics Corp. | 3.21 Million USD | -8631.643% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1567.469% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -11510.881% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -22154.462% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -248249.558% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -27093.314% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -8783.666% |
| scPharmaceuticals Inc. | 40.26 Million USD | -596.901% |
| HilleVax, Inc. | 51.19 Million USD | -448.19% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -422.52% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2990.353% |
| Immunic, Inc. | 1.33 Million USD | -20937.106% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Aptorum Group Limited | 3.36 Million USD | -8246.278% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -69536.476% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2990.353% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -13035.582% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1577.335% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -12952.791% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 36.944% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -96789.965% |
| bluebird bio, Inc. | 330.32 Million USD | 15.043% |
| DBV Technologies S.A. | 14.38 Million USD | -1851.429% |
| Compugen Ltd. | 1.35 Million USD | -20672.391% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Peak Bio, Inc. | 10.72 Million USD | -2517.423% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -11116.427% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -4420.538% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -16535.151% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -556.211% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -5942.959% |
| Benitec Biopharma Inc. | 284 Thousand USD | -98715.141% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -231.896% |
| Adicet Bio, Inc. | 20.92 Million USD | -1241.211% |
| Prime Medicine, Inc. | 13.63 Million USD | -1958.498% |
| Aditxt, Inc. | 18.21 Million USD | -1440.428% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -139.464% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1733.856% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -34614.783% |
| PolyPid Ltd. | 11.77 Million USD | -2282.503% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -206.846% |
| Invivyd, Inc. | 2.16 Million USD | -12862.356% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -7964045.948% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -363.255% |
| CorMedix Inc. | 667.63 Thousand USD | -41934.384% |
| Instil Bio, Inc. | 86.05 Million USD | -226.115% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -453.827% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -45.262% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -831.538% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -4962.872% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2013.852% |
| AbCellera Biologics Inc. | 77.38 Million USD | -262.671% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -236.537% |
| Surrozen, Inc. | 3.37 Million USD | -8205.268% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1043.489% |
| Verona Pharma plc | 51.32 Million USD | -446.738% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -46439.801% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -125.337% |
| Evaxion Biotech A/S | 10.86 Million USD | -2481.815% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -274.645% |
| Shattuck Labs, Inc. | 4.2 Million USD | -6578.605% |
| AlloVir, Inc. | 27.42 Million USD | -923.132% |
| BioVie Inc. | 6.11 Million USD | -4491.957% |
| Codexis, Inc. | 22.36 Million USD | -1154.852% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -30875.166% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -171053.342% |
| Agenus Inc. | 350.24 Million USD | 19.875% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -125015.916% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -119588.576% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1233.31% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1343.224% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Celcuity Inc. | 37.44 Million USD | -649.434% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -12958.865% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -885.134% |
| IN8bio, Inc. | 4.89 Million USD | -5635.438% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -20874.215% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -164.59% |
| Liquidia Corporation | 3.5 Million USD | -7911.276% |
| Quantum-Si incorporated | 15.3 Million USD | -1733.856% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -343478.599% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -2473.925% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -16877.314% |
| United Therapeutics Corporation | 700 Million USD | 59.909% |
| Solid Biosciences Inc. | 26.26 Million USD | -968.475% |
| Immuneering Corporation | 4.46 Million USD | -6188.093% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2013.852% |
| uniQure N.V. | 138.4 Million USD | -102.758% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -2349.463% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -228.524% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -58981.053% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -2012.261% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -133225.257% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1809.731% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -102321.533% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -831.198% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -28390.863% |
| Immunome, Inc. | 1.65 Million USD | -16908.182% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -16093.595% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -2770.065% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -828.971% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -77423.481% |
| Altimmune, Inc. | 671 Thousand USD | -41723.398% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -442.028% |
| Rallybio Corporation | 392 Thousand USD | -71490.561% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -6612.15% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -47871.795% |
| Moolec Science SA | 2.64 Million USD | -10508.86% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -67522.892% |
| NeurAxis, Inc. | 224.26 Thousand USD | -125038.232% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 54.067% |
| Lumos Pharma, Inc. | 6.58 Million USD | -4161.731% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -2770.065% |
| 180 Life Sciences Corp. | 1.32 Million USD | -21159.116% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1308.74% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1543.05% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -17947.267% |
| Nutriband Inc. | 241.28 Thousand USD | -116208.515% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -33875.182% |
| argenx SE | 20 Million USD | -1303.175% |
| Neurogene Inc. | 16.25 Million USD | -1626.453% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 8.927% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -883.27% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 17.81 Million USD | -1475.362% |
| Design Therapeutics, Inc. | 3.05 Million USD | -9101.148% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -107012.595% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1872.414% |
| Achilles Therapeutics plc | 4.61 Million USD | -5980.932% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -197530.282% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -2647.821% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 24.908% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -832.373% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -7489.107% |
| Palisade Bio, Inc. | 369 Thousand USD | -75952.846% |
| Beam Therapeutics Inc. | 173.17 Million USD | -62.055% |
| AEON Biopharma, Inc. | 278 Thousand USD | -100847.842% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -83671.642% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -262443.151% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -269.928% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -359.252% |
| Athira Pharma, Inc. | 1.58 Million USD | -17605.678% |
| Vaccinex, Inc. | 247 Thousand USD | -113517.409% |
| HCW Biologics Inc. | 6.45 Million USD | -4249.732% |
| XOMA Corporation | 124.45 Million USD | -125.5% |
| Nektar Therapeutics | 230.4 Million USD | -21.803% |
| Arvinas, Inc. | 3.4 Million USD | -8153.971% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -17098.67% |
| Merus N.V. | 12.16 Million USD | -2207.474% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -118.515% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1931.526% |
| Rezolute, Inc. | 2.22 Million USD | -12495.826% |
| Clene Inc. | 32.16 Million USD | -772.594% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -160214.305% |
| BeyondSpring Inc. | 3.99 Million USD | -6924.656% |
| Synlogic, Inc. | 17.27 Million USD | -1524.515% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -21487.308% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -801714.286% |
| Peak Bio, Inc. | 10.72 Million USD | -2517.423% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -440.483% |
| Krystal Biotech, Inc. | 8.09 Million USD | -3367.198% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -58.537% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -3876.69% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -205351.923% |
| MannKind Corporation | 382.37 Million USD | 26.608% |
| Ikena Oncology, Inc. | 10.73 Million USD | -2513.476% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -68514.914% |
| Gossamer Bio, Inc. | 212.46 Million USD | -32.086% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -161184.483% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2963.366% |
| Legend Biotech Corporation | 328.67 Million USD | 14.615% |
| Mural Oncology plc | 15 Million USD | -1769.778% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -491.732% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -13257.211% |
| Champions Oncology, Inc. | 7.43 Million USD | -3677.052% |
| REGENXBIO Inc. | 89.29 Million USD | -214.296% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -32734.443% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -50649.391% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -5083.506% |
| Vaxart, Inc. | 26.51 Million USD | -958.441% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1692.352% |
| Cellectis S.A. | 92.85 Million USD | -202.236% |
| Longeveron Inc. | 2.04 Million USD | -13649.878% |
| Repare Therapeutics Inc. | 3.41 Million USD | -8129.765% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 79.909% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -502.324% |
| Revolution Medicines, Inc. | 87.94 Million USD | -219.106% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -162116.763% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -6999.292% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -88428.391% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -160262.857% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 65.285% |
| Denali Therapeutics Inc. | 52.24 Million USD | -437.193% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1848.115% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -20324.672% |
| Cingulate Inc. | 3.13 Million USD | -8851.392% |
| Passage Bio, Inc. | 26.29 Million USD | -967.297% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -4110.578% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -68683.088% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -31290.94% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -219.106% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1264.89% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -22172.619% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -11349.251% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -8886.071% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -34503.576% |
| OmniAb, Inc. | 25.56 Million USD | -997.903% |
| Anew Medical, Inc. | 1.6 Million USD | -17385.047% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -848.64% |
| Lipocine Inc. | 17.16 Thousand USD | -1634730.479% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -2311.368% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -710.428% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -4650.841% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -390.852% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -138143.842% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -5333.398% |
| Ocugen, Inc. | 6.94 Million USD | -3943.149% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1886.234% |
| Q32 Bio Inc. | 1.31 Million USD | -21192.489% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -41661.161% |
| Alumis Inc. Common Stock | 32.58 Million USD | -761.372% |
| Equillium, Inc. | 824 Thousand USD | -33957.646% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -2991.034% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -93194.349% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -84.266% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -448.78% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -36108.725% |
| Dominari Holdings Inc. | 3.02 Million USD | -9167.999% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -296909.112% |
| vTv Therapeutics Inc. | 529 Thousand USD | -52950.095% |
| Bio-Techne Corporation | 419.53 Million USD | 33.109% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -289.792% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -44.982% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1561.742% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1132.91% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -4532.469% |
| Nkarta, Inc. | 88.33 Million USD | -217.68% |
| BioCardia, Inc. | 1.31 Million USD | -21241.065% |
| Iterum Therapeutics plc | 19.5 Million USD | -1338.49% |